Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Generalized Epilepsy”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Ended earlyNCT00693017
What this trial is testing

Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

Who this might be right for
Epilepsy
Eisai Limited 10
Large-scale testing (Phase 3)Study completedNCT03678753
What this trial is testing

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

Who this might be right for
Primary Generalized Epilepsy
SK Life Science, Inc. 169
Post-approval studies (Phase 4)Study completedNCT04899050
What this trial is testing

Epidiolex in Typical Absence Seizures

Who this might be right for
Study the Efficacy of Epidiolex for Typical Absence Seizures
University of South Florida 14
Testing effectiveness (Phase 2)Study completedNCT01118962
What this trial is testing

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 39
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)Study completedNCT02408549
What this trial is testing

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 239
Not applicableStudy completedNCT05374928
What this trial is testing

Human Epilepsy Project 3

Who this might be right for
Idiopathic Generalized Epilepsy
NYU Langone Health 316
Not applicableStudy completedNCT00552045
What this trial is testing

Epilepsy Phenome/Genome Project

Who this might be right for
EpilepsyLocalization-related EpilepsyInfantile Spasms+3 more
University of California, San Francisco 4,150
Not applicableStudy completedNCT06393309
What this trial is testing

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

Who this might be right for
Treatment of Idiopathic Generalized Epilepsy
Mazandaran University of Medical Sciences 169
Large-scale testing (Phase 3)Study completedNCT05297695
What this trial is testing

Helicobacter Pylori Eradication Therapy for Epileptic Children

Who this might be right for
Epilepsy, GeneralizedHelicobacter Pylori Infection
Sohag University 126
Not applicableEnded earlyNCT00916903
What this trial is testing

Genetic Disease Gene Identification

Who this might be right for
Congenital Vertical TalusFamilial Encephalopathy With Neuroserpin Inclusion BodiesIdiopathic Generalised Epilepsy+2 more
State University of New York - Upstate Medical University 176
Not applicableNot Yet RecruitingNCT07803692
What this trial is testing

High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 Years

Who this might be right for
Idiopathic Generalized Epilepsy
Oregon Health and Science University 10
Not applicableStudy completedNCT05097742
What this trial is testing

Cognitive Impairments in Children With Epilepsy

Who this might be right for
Epilepsy Syndrome
University Hospital, Montpellier 30
Post-approval studies (Phase 4)Study completedNCT00267202
What this trial is testing

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma

Who this might be right for
Allergic Asthma
Novartis 275
Not applicableActive Not RecruitingNCT06481280
What this trial is testing

Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.

Who this might be right for
Cow's Milk Allergy
United Pharmaceuticals 70
Not applicableStudy completedNCT02722590
What this trial is testing

Fycompa (Perampanel) in Korean Participants

Who this might be right for
Epilepsy
Eisai Korea Inc. 3,692
Post-approval studies (Phase 4)Study completedNCT00670930
What this trial is testing

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT00236886
What this trial is testing

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Who this might be right for
EpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Not applicableEnded earlyNCT05530109
What this trial is testing

Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.

Who this might be right for
Idiopathic Generalized Epilepsy
University Hospital, Lille 33
Testing effectiveness (Phase 2)Study completedNCT01703312
What this trial is testing

A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 37
Next Page